Equimax Horse Wormer

Below is the product datasheet. This has been provided by the manufacturer and should always be provided with the medication.

Introduction

Company name: Virbac Limited
Address: Woolpit Business Park
Windmill Avenue
Woolpit
Bury St Edmunds
Suffolk
IP30 9UP
Telephone: 01359 243243
Fax: 01359 243200
Website: www.virbac.co.uk
 

Presentation

A white homogenous, oral gel containing:
1.87% w/w ivermectin Ph.Eur.
14.03% w/w praziquantel Ph.Eur.
 

Uses

For the treatment and control of adult and immature gastrointestinal roundworms, lungworms, bots and tapeworms of horses, including:
Large strongyles
Strongylus vulgaris adults and 4th larval (arterial) stages
Strongylus edentatus adults and 4th larval (tissue) stages
Strongylus equinus adults
Triodontophorus spp adults
Small strongyles, adults
Cyathostomum spp.
Cylicocyclus spp.
Cylicodontophorus spp.
Cylicostephanus spp.
Gyalocephalus spp.
Hairworms
Trichostrongylus axei adults
Pinworms
Oxyuris equi adults and immatures
Ascarids
Parascaris equorum adults and immatures
Intestinal threadworms
Strongyloides westeri adults
Large-mouth stomach worms
Habronema muscae adults
Neck threadworms
Onchocerca spp. (microfilariae)
Lungworms
Dictyocaulus arnfieldi adult and immature
Stomach bots
Gasterophilus spp. oral and gastric larval stages
Tapeworms
Anoplocephala perfoliata
Anoplocephala magna
Paranoplocephala mamillana
 

Dosage and administration

Equimax Oral Paste for Horses is given by mouth at the recommended dose rate of 200 micrograms of ivermectin and 1.5mg of praziquantel per kg of bodyweight as a single dose, corresponding to 1.07g of paste per 100kg bodyweight. The first syringe division delivers sufficient paste to treat 100kg of bodyweight. Each subsequent syringe division delivers sufficient paste to treat 50kg of bodyweight. The syringe delivers sufficient paste to treat 700kg bodyweight at the recommended dose rate.
The horse’s weight should be accurately determined to ensure use of the correct dose of product.
Before administration adjust the syringe to the calculated dosage by setting the ring on the plunger.

The animal’s mouth must be free of food. The syringe should be placed between the front and back teeth and the paste deposited at the base of the tongue. Immediately elevate the head for a few seconds to ensure that the product is swallowed. Treatment is recommended at least twice a year, in spring and autumn or according to veterinary advice. Intermediate roundworm treatment is advisable.
 

Contra-indications, warnings, etc

For animal treatment only.
Not to be used in foals under two weeks of age.
Some horses carrying heavy infection of Onchocerca microfilariae have experienced reactions with swelling and itching after treatment. It is assumed to be the result of death of large numbers of microfilariae.
These signs resolve within a few days but symptomatic treatment may be advisable.
Equimax Oral paste for Horses has been formulated specifically for use in horses. Dogs and cats may be adversely affected by the concentration of ivermectin in this product, if they are allowed to ingest spilled paste or have access to used syringes.
As ivermectin is extremely dangerous to fish and aquatic life, treated animals should not have direct access to surface water and ditches during treatment.
Wash hands after use.
Avoid eye contact.
Do not smoke or eat while handling the product.
Withdrawal period
Horses may be slaughtered for human consumption only after 35 days from the last treatment.
Container disposal
Any unused product or waste material should be disposed of in accordance with local requirements. Ivermectin is EXTREMELY DANGEROUS TO FISH AND AQUATIC LIFE. Do not contaminate surface water or ditches with the product or used containers.
 

Pharmaceutical precautions

Keep out of the reach of children. Store below 30° C. Part-used syringes should be stored below 25° C.
Following withdrawal of the first dose, use the product within 6 months.
 

Legal category

POM-VPS
 

Packaging Quantities

12 syringes, each containing 7.49g of 1.87% w/w ivermectin and 14.03% w/w praziquantel paste.
 

Further information

No known interaction with other equine medicaments.
Studies in other species showed no teratogenic or embryotoxic effect from either ivermectin or praziquantel at the recommended doses during therapy.
A tolerance study performed in foals from 2 weeks of age with doses up to 5 times the recommended dosage showed no adverse reactions.
Safety studies conducted with Equimax administered to mares at 3 times the recommended dosage at 14 day intervals during the whole gestation and lactation did not show any abortions, any adverse effects on the gestation, parturition and on the mares general health, nor any abnormalities on the foals.
Safety studies conducted with Equimax administered to stallions at 3 times the recommended dosage did not show any adverse effects in particular on the reproductive performances.
 

Marketing authorisation number

Vm 16971/4004.